Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Human source anti- tetanus exotoxin antibody and preparation method and use thereof

An anti-tetanus and exotoxin technology, applied in the fields of botanical equipment and methods, biochemical equipment and methods, antibodies, etc., can solve problems such as insufficient blood supply

Inactive Publication Date: 2008-06-04
北京明新高科技发展有限公司 +2
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The human anti-tetanus toxin antibody prepared by this method can avoid allergic reactions caused by heterogeneous serum proteins, and can overcome the problems of insufficient blood source and pathogen contamination in the production of human immunoglobulins

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Human source anti- tetanus exotoxin antibody and preparation method and use thereof
  • Human source anti- tetanus exotoxin antibody and preparation method and use thereof
  • Human source anti- tetanus exotoxin antibody and preparation method and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0110] Phagemid pComb 3 (4000bp) was produced by Scripps Research Institute of the United States; XL1-Blue and helper phage VCSM13 were purchased from Stratagene Company of the United States; Trizol was purchased from Gibco-BRL Company; PCR kits, restriction enzymes, T4DNA ligase Purchased from Promega; tetanus exotoxin and standard human tetanus immunoglobulin (TIG) were purchased from China National Institute for the Control of Pharmaceutical and Biological Products. Goat anti-human IgG Fab, inducer IPTG (isopropyl-β-d-thiogalactoside), chromogen OPD (o-phenylenediamine), and 3-morpholine propanesulfonic acid (MOPS) were all from Sigma product. Yeast and CHO were purchased from Promega.

[0111] 1. PCR amplification of human IgG Fab segment gene:

[0112] Lymphocytes were isolated from the anticoagulated blood of volunteers immunized with tetanus toxoid for 6 days with lymphocyte separation medium, total cellular RNA was extracted with Trizol, and the extracted RNA was rev...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a human source anti-tetanus exotoxin antibody (HTAT-Fab) and preparation method, comprising: constructing human immunity phage antibody bank, screening phage positive clone, further getting HTAT-Fab gene with a specific neutralization activity and high affinity. The gene can be expressed in the procaryotic cell such as E.coli, eukaryotic cell such as microzyme, or mammalian cell such as CHO, purifying to get highly purified HTAT-Fab with a strong tissue penetrability, a high affinity. The HTAT-Fab product can not only eliminate the allergic reaction generated by horse serum anti-tatanus antitoxin (TAT) (foreign protein), but also avoid the blood source for producing human tetanus immunoglobulin (HTIG) and the latent virus pollution.

Description

field of invention [0001] The invention relates to humanized anti-tetanus exotoxin antibody (HTAT-Fab), its preparation method and application, and belongs to the field of biological products. Background technique [0002] Tetanus (tetanus) disease is an acute infectious disease characterized by muscle tonic spasm caused by tetanus bacilli invading human wounds and multiplying in anaerobic environment to produce neurotropic exotoxins. Severe patients may die due to laryngospasm or secondary severe lung infection; neonatal and severe patients, the case fatality rate can be as high as 20-50%; about 50,000 people die of tetanus every year in the world. Tetanus antitoxin (TAT) or human tetanus immunoglobulin (Human Tetanusimmunoglulin, HTIG) injections are often required in an effective tetanus prevention and treatment program. According to incomplete statistics, the domestic demand for TAT and HTIG has reached more than 10 million servings / year, and the international demand is...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/08C12N15/12A61K39/395A61P31/04
Inventor 高尚先张利宁孙汶生王群王福清刘军莉赵强
Owner 北京明新高科技发展有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com